Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Woomera Therapeutics for $149,819.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA177025-01A1 | Phase I | 149,819 | ||||||||
A SBIR Phase I contract was awarded to Woomera Therapeutics for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA119483-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Woomera Therapeutics for $100,001.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA162613-01 | Phase I | 100,001 | ||||||||
A SBIR Phase II contract was awarded to Woomera Therapeutics for $688,433.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA119483-02A1 | Phase II | 688,433 | ||||||||
A SBIR Phase II contract was awarded to Woomera Therapeutics for $986,459.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA162613-02 | Phase II | 986,459 |